Shortwave Infrared-Emitting Theranostics for Breast Cancer Therapy Response Monitoring

Therapeutic drug monitoring (TDM) in cancer, while imperative, has been challenging due to inter-patient variability in drug pharmacokinetics. Additionally, most pharmacokinetic monitoring is done by assessments of the drugs in plasma, which is not an accurate gauge for drug concentrations in target...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Jay V., Gonda, Amber, Pemmaraju, Rahul, Subash, Aishwarya, Bobadilla Mendez, Carolina, Berger, Marissa, Zhao, Xinyu, He, Shuqing, Riman, Richard E., Tan, Mei Chee, Pierce, Mark C., Moghe, Prabhas V., Ganapathy, Vidya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575924/
https://www.ncbi.nlm.nih.gov/pubmed/33134314
http://dx.doi.org/10.3389/fmolb.2020.569415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575924/
https://www.ncbi.nlm.nih.gov/pubmed/33134314
http://dx.doi.org/10.3389/fmolb.2020.569415

Ejemplares similares